For reprint rights or to purchase a copy of your Daily Journal photo, email jeremy@reprintpros.com for prices or call 949-702-5390.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Transactions

Dec. 18, 2001

Mintz Levin: OSI PHARMACEUTICALS WILL ADOPT FOSTER CITY COMPANY

OSI Pharmaceuticals will acquire Gilead Sciences' assets from its oncology business. OSI will acquire Gilead's clinical candidates in oncology, its intellectual property, including clinical research and drug development personnel, and its Boulder, Colo. operations. The cash and stock deal is valued at $200 million.

        OSI Pharmaceuticals will acquire Gilead Sciences' assets from its oncology business.
        OSI will acquire Gilead's clinical candidates in oncology, its intellectual property, including clinical research and drug development personnel, and its Boulder, Colo. operations. The cash and stock deal is valued at $200 million.
        Uniondal...

To continue reading, please subscribe.

Already a subscriber?

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.